Post-Transplantation Immunosuppression After TCRΑβ/CD19 Graft Depletion Does Not Improve HSCT Outcomes in Primary Immunodeficiency-Reference-Cited by-同舟云学术

Post-Transplantation Immunosuppression After TCRΑβ/CD19 Graft Depletion Does Not Improve HSCT Outcomes in Primary Immunodeficiency

Published:2021-12 Issue: Volume: Page:
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Laberko Alexandra^ORCID,Idarmacheva Aishat^ORCID,Glushkova Svetlana^ORCID,Pershin Dmitry^ORCID,Shelikhova Larisa,Maschan Michael,Maschan Alexei,Balashov Dmitry

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference15 articles.

1. Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directions;Martinez-Cibrian;Blood Rev,2021

2. HLA-haploidentical stem cell transplantation after removal of + T and B cells in children with nonmalignant disorders;Bertaina;Blood,2014

3. T-cell receptor αβ + and CD19 + cell–depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency;Shah;J Allergy Clin Immunol,2018

4. Use of TCR α+β+/CD19+–depleted haploidentical hematopoietic stem cell transplant is a viable option in patients with primary immune deficiency without matched sibling donor;Brettig;J Clin Immunol,2019

5. Mismatched related vs matched unrelated donors in TCRαβ/CD19-depleted HSCT for primary immunodeficiencies;Laberko;Blood,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IV Joint Congress of RSPOH “Actual problems and prospects for the development of pediatric oncology and hematology in the Russian Federation – 2023”. Resolution on the results of the satellite symposium “Tepadina in oncohematology: forgotten opportunities and new horizons”;Russian Journal of Pediatric Hematology and Oncology;2024-01-16

2. Progress in the field of hematopoietic stem cell-based therapies for inborn errors of immunity;Current Opinion in Pediatrics;2023-09-21